Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2002

View Archived Issues

Exclusive rights to key P. falciparum protein obtained by AdProTech

Hydro Med accelerates phase III development of Histrelin implant

Ciclesonide: site-activated inhaled corticosteroid with a promising profile for asthma Rx

Low-molecular-weight compound restores function of the p53 gene

Calpain inhibitor selected for development in ocular diseases

Specific ROCK inhibitor with potential as a novel glaucoma treatment

Anti-VEGF aptamer improves vision without adverse events in AMD patients

Edaravone should be evaluated in humans for ocular oxidative stress according to preclinical data

KL-6 is an effective serum marker for interstitial lung diseases

Onyx shifts business emphasis to clinical development

NeuroSearch and GSK discontinue development of NS-2389

AstraZeneca submits sNDA for Arimidex in early breast cancer

Hybridon initiates phase I/II trial of GEM-231/irinotecan in solid tumors

Interleukin Genetics and UAMS collaborate in Alzheimer's disease

SuperGen and Abbott conclude alliance

Ribozyme and Fujirebio collaborate to develop ribozyme-based clinical diagnostics

Zetiq identifies new potential colon cancer drug candidates

TRK-820 effective against both antihistamine-sensitive and -resistant pruritus

TZT-1027 exhibits enhanced activity against cytokine-secreting tumors

B7 protein PD-L2 described in patent

Complexes for use in in vivo diagnosis of hepatic fibrosis or necrosis

Vitronectin receptor antagonists for use in osteoporosis, etc.

Antagonists of NK1 receptors for use in irritable bowel syndrome and other GI disorders

Synaptic identifies new compounds for eating disorders

Zinc hydrolase inhibitors for use in ECE-mediated conditions

Compounds identified by Bayer with potential in ischemia-reperfusion injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...